Latest Biotech News

Karyopharm Therapeutics announced a 20% workforce reduction, citing limited success in securing strategic alternatives to sustain operations. The company faces financial strain with a $1.6 billion...

Recent analyses highlight compensation trends among top biopharma CEOs, reflecting growing investor focus on executive pay within the industry. These data provide insight into leadership...

Radiopharma developers Actithera and Nuclidium secured new venture capital rounds, underscoring investor interest in targeted radioligand therapies. Additional financing activities include private...

Healthcare experts emphasize that better navigation systems are essential to enhance behavioral health outcomes. Emerging technologies promise improved patient support but must be complemented by...

Amid tariff challenges and supply uncertainties, healthcare stakeholders advocate for transforming supply chains from transactional models to strategic partnerships emphasizing domestic sourcing...

Johns Hopkins University researchers have uncovered over 200 types of misfolded proteins potentially linked to age-related cognitive decline, expanding Alzheimer's disease research beyond the...

Repligen and Univercells Technologies have partnered to integrate Repligen’s MAVEN® Real Time Glucose Control Platform with Univercells’ scale-X bioreactors. This collaboration enables real-time...

Fecal microbiota transplantation (FMT), initially established for treating recurrent Clostridioides difficile infections, is gaining attention for broader therapeutic applications. Since 2017,...

The FDA has issued a complete response letter to Capricor Therapeutics, requesting additional efficacy data for Deramiocel, its off-the-shelf cell therapy targeting cardiac complications of...

Jason Beckwith, PhD, highlights an imminent 'talent singularity' in biomanufacturing expected by 2028, where demand for skilled professionals will outpace supply. The industry faces shortages due...

The FDA approved three new molecular entities (NMEs) in June 2025, contributing to a total of 19 approvals so far this year, signaling continued drug pipeline activity. Concurrently, Commissioner...

Biopharma financing has shown notable activity in 2025, encompassing public and private rounds. Early-year data revealed cumulative capital deployment across multiple funding categories,...

Radiopharma developers Actithera and Nuclidium secured venture capital investment as part of a broader funding wave encompassing Varda and Renasant, alongside public offerings from Rhythm, Cogent,...

Juniper Genomics announced a C$4.6 million seed funding round to expand its commercial and research operations focused on genomics testing for in vitro fertilization (IVF). Concurrently, Elon Musk...

Legislation introduced seeks to extend Medicare’s hospital-at-home reimbursement waiver through 2030, reinforcing the model’s role in reducing mortality and costs by enabling acute care in...

Researchers at Johns Hopkins University have used limited proteolysis mass spectrometry (LiP-MS) to uncover over 200 misfolded proteins potentially linked to age-related cognitive decline in a rat...

Capricor Therapeutics received a complete response letter (CRL) from the FDA rejecting its biologics license application for deramiocel, an off-the-shelf cell therapy targeting cardiomyopathy in...

Merck’s acquisition of Verona Pharma for $10 billion centers on Verona’s COPD drug, Ohtuvayre, whose main patent expired in 2020. For Merck to capitalize on the deal, secondary patents protecting...

Repligen Technologies and Univercells have partnered to integrate Repligen’s MAVEN® Real Time Glucose Control Platform into Univercells’ scale-X bioreactors to enable continuous monitoring of...

Biopharma dealmaking skyrocketed in June 2025, reaching $35.07 billion, marking the highest monthly total of the year and contributing to a first-half 2025 deal value of $138.31 billion. This...